Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Fulminant hepatic failure due to nilutamide hepatotoxicity.

× No keyword cloud information.

16 in total

1. Tolerability of Nonsteroidal Antiandrogens in the Treatment of Advanced Prostate Cancer.

Authors:
Journal: Oncologist Date: 1997

2. Fatal and nonfatal hepatotoxicity associated with flutamide.

Authors: D K Wysowski; J P Freiman; J B Tourtelot; M L Horton
Journal: Ann Intern Med Date: 1993-06-01 Impact factor: 25.391

3. Inhibition by nilutamide of the mitochondrial respiratory chain and ATP formation. Possible contribution to the adverse effects of this antiandrogen.

Authors: A Berson; L Schmets; C Fisch; D Fau; C Wolf; B Fromenty; D Deschamps; D Pessayre
Journal: J Pharmacol Exp Ther Date: 1994-07 Impact factor: 4.030

4. Efficacy of the combination of nilutamide plus orchidectomy in patients with metastatic prostatic cancer. A meta-analysis of seven randomized double-blind trials (1056 patients).

Authors: C Bertagna; A De Géry; M Hucher; J P François; J Zanirato
Journal: Br J Urol Date: 1994-04

5. Anandron (RU 23908) in metastatic prostate cancer: preliminary results of a multicentric Italian study.

Authors: F Boccardo; A U Decensi; D Guarneri; G Martorana; L Fioretto; E Mini; M P Macaluso; L Giuliani; L Santi; P Periti
Journal: Cancer Detect Prev Date: 1991

6. Mechanism for the hepatotoxicity of the antiandrogen, nilutamide. Evidence suggesting that redox cycling of this nitroaromatic drug leads to oxidative stress in isolated hepatocytes.

Authors: D Fau; A Berson; D Eugene; B Fromenty; C Fisch; D Pessayre
Journal: J Pharmacol Exp Ther Date: 1992-10 Impact factor: 4.030

7. Monotherapy with nilutamide, a pure nonsteroidal antiandrogen, in untreated patients with metastatic carcinoma of the prostate. The Italian Prostatic Cancer Project.

Authors: A U Decensi; F Boccardo; D Guarneri; N Positano; M C Paoletti; M Costantini; G Martorana; L Giuliani
Journal: J Urol Date: 1991-08 Impact factor: 7.450

Review 8. Advances and trends in hormonal therapy for advanced prostate cancer.

Authors: F M Debruyne; G A Dijkman
Journal: Eur Urol Date: 1995 Impact factor: 20.096

9. Orchiectomy and nilutamide or placebo as treatment of metastatic prostatic cancer in a multinational double-blind randomized trial.

Authors: R A Janknegt; C C Abbou; R Bartoletti; L Bernstein-Hahn; B Bracken; J M Brisset; F C Da Silva; G Chisholm; E D Crawford; F M Debruyne
Journal: J Urol Date: 1993-01 Impact factor: 7.450

10. [Fatal fulminant hepatitis induced by nilutamide (Anandron)].

Authors: P Pescatore; P Hammel; F Durand; P Bertheau; J Bernuau; D Huc; J L Gerbal; C Degott; J P Benhamou
Journal: Gastroenterol Clin Biol Date: 1993